Biology Reference
In-Depth Information
13. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE et al (2005) A
microRNA signature associated with prognosis and progression in chronic lymphocytic leuke-
mia. N Engl J Med 353(17):1793-1801
14. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M et al (2005) miR-15 and
miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102(39):13944-13949
15. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L et al (2008) The miR-
15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat
Med 14(11):1271-1277
16. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F et al (2006) A microRNA
expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci
USA 103(7):2257-2261
17. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S et al (2008)
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and
stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27(15):
2128-2136
18. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH (2008) Programmed
cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast
cancer cells. J Biol Chem 283(2):1026-1033
19. Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH et al (2008) MicroRNA-21
promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene
27(31):4373-4379
20. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T (2007) MicroRNA-21 regu-
lates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.
Gastroenterology 133(2):647-658
21. Vasudevan S, Tong Y, Steitz JA (2007) Switching from repression to activation: microRNAs
can up-regulate translation. Science 318(5858):1931-1934
22. Krutzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M et al (2005) Silencing
of microRNAs in vivo with 'antagomirs'. Nature 438(7068):685-689
23. Esau C, Davis S, Murray SF, Yu XX, Pandey SK, Pear M et al (2006) miR-122 regulation of
lipid metabolism revealed by in vivo antisense targeting. Cell Metab 3(2):87-98
24. Eckstein F (2007) The versatility of oligonucleotides as potential therapeutics. Expert Opin
Biol Ther 7(7):1021-1034
25. Krutzfeldt J, Kuwajima S, Braich R, Rajeev KG, Pena J, Tuschl T et al (2007) Specificity,
duplex degradation and subcellular localization of antagomirs. Nucleic Acids Res
35(9):2885-2892
26. Preis M, Gardner TB, Gordon SR, Pipas JM, Mackenzie TA, Klein EE et al (2011) MicroRNA-
10b expression correlates with response to neoadjuvant therapy and survival in pancreatic
ductal adenocarcinoma. Clin Cancer Res 17(17):5812-5821
27. Elmen J, Lindow M, Schutz S, Lawrence M, Petri A, Obad S et al (2008) LNA-mediated
microRNA silencing in non-human primates. Nature 452(7189):896-899
28. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P (2005) Modulation of hepatitis C
virus RNA abundance by a liver-specific MicroRNA. Science 309(5740):1577-1581
29. Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by
microRNA-10b in breast cancer. Nature 449(7163):682-688
30. Sasayama T, Nishihara M, Kondoh T, Hosoda K, Kohmura E (2009) MicroRNA-10b is over-
expressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC.
Int J Cancer 125(6):1407-1413
31. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S et al (2008)
MicroRNA profiling in hepatocellular tumors is associated with clinical features and onco-
gene/tumor suppressor gene mutations. Hepatology 47(6):1955-1963
32. Rojas-Fernandez CH, Lapane KL, MacKnight C, Howard KA (2002) Undertreatment of
osteoporosis in residents of nursing homes: population-based study with use of the Systematic
Assessment of Geriatric Drug Use via Epidemiology (SAGE) database. Endocr Pract
8(5):335-342
Search WWH ::




Custom Search